iguratimod has been researched along with Cancer of Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Q; Huang, X; Shan, H; Wu, Y; Younis, M | 1 |
1 other study(ies) available for iguratimod and Cancer of Lung
| Article | Year |
|---|---|
Synergistic therapeutic antitumor effect of PD-1 blockade cellular vesicles in combination with Iguratimod and Rhodium nanoparticles.
Topics: Cell Line, Tumor; Humans; Lung Neoplasms; Nanoparticles; Programmed Cell Death 1 Receptor; Rhodium | 2023 |